Popular on the website
- The UN drugs debate goes virtual: Greater inclusion but common divisions
- Taking stock of half a decade of drug policy - An evaluation of UNGASS implementation
- A message from our Executive Director: Six drug policy takeaways from 2020
- Coronavirus disease (COVID-19): Resources and information
- Roadmap for key populations advocates navigating the global fund
